Optimizing an NGS low-pass–based method to detect genomic instability as a PARP inhibitor predictive biomarker in high-grade serous ovarian cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results